Concepedia

Publication | Open Access

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

DOIFull Paper Access

309

Citations

19

References

2010

Year

Julio Rosenstock, Salomon Banarer, Vivian Fonseca, Silvio E. Inzucchi, William Sun, Wenqing Yao, Gregory Hollis, Robert Flores, Richard Levy, William V. Williams,
Diabetes Care

Abstract

INCB13739 added to ongoing metformin therapy was efficacious and well tolerated in patients with type 2 diabetes who had inadequate glycemic control with metformin alone. 11BetaHSD1 inhibition offers a new potential approach to control glucose and cardiovascular risk factors in type 2 diabetes.

References

YearCitations

Page 1